ID ZN217_HUMAN Reviewed; 1048 AA. AC O75362; E1P5Y6; Q14DB8; DT 24-JAN-2001, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1998, sequence version 1. DT 27-MAR-2024, entry version 202. DE RecName: Full=Zinc finger protein 217; GN Name=ZNF217; Synonyms=ZABC1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=9671742; DOI=10.1073/pnas.95.15.8703; RA Collins C., Rommens J.M., Kowbel D., Godfrey T., Tanner M., Hwang S.-I., RA Polikoff D., Nonet G., Cochran J., Myambo K., Jay K.E., Froula J., RA Cloutier T., Kuo W.-L., Yaswen P., Dairkee S., Giovanola J., RA Hutchinson G.B., Isola J., Kallioniemi O.-P., Palazzolo M., Martin C., RA Ericsson C., Pinkel D., Albertson D., Li W.-B., Gray J.W.; RT "Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and RT overexpressed in breast carcinoma."; RL Proc. Natl. Acad. Sci. U.S.A. 95:8703-8708(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=11780052; DOI=10.1038/414865a; RA Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., RA Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., RA Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., RA Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D., RA Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G., RA Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E., RA Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D., RA Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., RA Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., RA Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., RA Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., RA Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., RA Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., RA Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., RA Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., RA Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., RA Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M., RA Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D., RA Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M., RA Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A., RA Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L., RA Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L., RA Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 20."; RL Nature 414:865-871(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION IN THE BHC COMPLEX WITH GSE1; GTF2I; HDAC1; HDAC2; HMG20B; RP KDM1A; PHF21A; RCOR1; ZMYM2 AND ZMYM3. RX PubMed=12493763; DOI=10.1074/jbc.m208992200; RA Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.; RT "A candidate X-linked mental retardation gene is a component of a new RT family of histone deacetylase-containing complexes."; RL J. Biol. Chem. 278:7234-7239(2003). RN [6] RP FUNCTION. RX PubMed=16203743; DOI=10.1093/hmg/ddi352; RA Huang G., Krig S., Kowbel D., Xu H., Hyun B., Volik S., Feuerstein B., RA Mills G.B., Stokoe D., Yaswen P., Collins C.; RT "ZNF217 suppresses cell death associated with chemotherapy and telomere RT dysfunction."; RL Hum. Mol. Genet. 14:3219-3225(2005). RN [7] RP FUNCTION. RX PubMed=17259635; DOI=10.1074/jbc.m611752200; RA Krig S.R., Jin V.X., Bieda M.C., O'Geen H., Yaswen P., Green R., RA Farnham P.J.; RT "Identification of genes directly regulated by the oncogene ZNF217 using RT chromatin immunoprecipitation (ChIP)-chip assays."; RL J. Biol. Chem. 282:9703-9712(2007). RN [8] RP SUBUNIT, IDENTIFICATION IN A COMPLEX WITH HDAC2; KDM1A AND CTBP1, AND RP FUNCTION. RX PubMed=18625718; DOI=10.1128/mcb.00246-08; RA Thillainadesan G., Isovic M., Loney E., Andrews J., Tini M., Torchia J.; RT "Genome analysis identifies the p15ink4b tumor suppressor as a direct RT target of the ZNF217/CoREST complex."; RL Mol. Cell. Biol. 28:6066-6077(2008). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-321; THR-322; THR-648 AND RP SER-662, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-795, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; SER-407; SER-593 AND RP SER-662, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [12] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-819, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [13] RP X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 752-760 IN COMPLEX WITH CTBP1, RP INTERACTION WITH CTBP1 AND CTBP2, AND FUNCTION. RX PubMed=16940172; DOI=10.1128/mcb.00680-06; RA Quinlan K.G.R., Nardini M., Verger A., Francescato P., Yaswen P., Corda D., RA Bolognesi M., Crossley M.; RT "Specific recognition of ZNF217 and other zinc finger proteins at a surface RT groove of C-terminal binding proteins."; RL Mol. Cell. Biol. 26:8159-8172(2006). RN [14] RP VARIANT [LARGE SCALE ANALYSIS] ASN-323. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., RA Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., RA Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., RA Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., RA Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal cancers."; RL Science 314:268-274(2006). CC -!- FUNCTION: Binds to the promoters of target genes and functions as CC repressor. Promotes cell proliferation and antagonizes cell death. CC Promotes phosphorylation of AKT1 at 'Ser-473'. CC {ECO:0000269|PubMed:16203743, ECO:0000269|PubMed:16940172, CC ECO:0000269|PubMed:17259635, ECO:0000269|PubMed:18625718}. CC -!- SUBUNIT: Component of a histone deacetylase complex that contains CC HDAC2, KDM1A, CTBP1 and ZNF217. May be a component of a BHC histone CC deacetylase complex that contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, CC RCOR1/CoREST, PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I. CC Interacts with CTBP1 and CTBP2. {ECO:0000269|PubMed:12493763, CC ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:18625718}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. CC -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein CC family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/42875/ZNF217"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF041259; AAC39895.1; -; mRNA. DR EMBL; AL157838; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471077; EAW75580.1; -; Genomic_DNA. DR EMBL; BC113427; AAI13428.1; -; mRNA. DR CCDS; CCDS13443.1; -. DR RefSeq; NP_006517.1; NM_006526.2. DR RefSeq; XP_016883548.1; XM_017028059.1. DR PDB; 2HU2; X-ray; 2.85 A; B=752-760. DR PDB; 3UK3; X-ray; 2.10 A; C/D=469-523. DR PDB; 4F2J; X-ray; 2.64 A; C=469-523. DR PDB; 4IS1; X-ray; 2.10 A; C/D=469-523. DR PDBsum; 2HU2; -. DR PDBsum; 3UK3; -. DR PDBsum; 4F2J; -. DR PDBsum; 4IS1; -. DR AlphaFoldDB; O75362; -. DR SMR; O75362; -. DR BioGRID; 113547; 85. DR CORUM; O75362; -. DR IntAct; O75362; 28. DR MINT; O75362; -. DR STRING; 9606.ENSP00000360526; -. DR GlyGen; O75362; 3 sites, 1 O-linked glycan (3 sites). DR iPTMnet; O75362; -. DR PhosphoSitePlus; O75362; -. DR SwissPalm; O75362; -. DR BioMuta; ZNF217; -. DR EPD; O75362; -. DR jPOST; O75362; -. DR MassIVE; O75362; -. DR MaxQB; O75362; -. DR PaxDb; 9606-ENSP00000360526; -. DR PeptideAtlas; O75362; -. DR ProteomicsDB; 49925; -. DR Pumba; O75362; -. DR Antibodypedia; 28736; 393 antibodies from 35 providers. DR DNASU; 7764; -. DR Ensembl; ENST00000302342.3; ENSP00000304308.3; ENSG00000171940.14. DR Ensembl; ENST00000371471.7; ENSP00000360526.2; ENSG00000171940.14. DR GeneID; 7764; -. DR KEGG; hsa:7764; -. DR MANE-Select; ENST00000371471.7; ENSP00000360526.2; NM_006526.3; NP_006517.1. DR UCSC; uc002xwq.5; human. DR AGR; HGNC:13009; -. DR CTD; 7764; -. DR DisGeNET; 7764; -. DR GeneCards; ZNF217; -. DR HGNC; HGNC:13009; ZNF217. DR HPA; ENSG00000171940; Low tissue specificity. DR MIM; 602967; gene. DR neXtProt; NX_O75362; -. DR OpenTargets; ENSG00000171940; -. DR PharmGKB; PA37588; -. DR VEuPathDB; HostDB:ENSG00000171940; -. DR eggNOG; KOG1721; Eukaryota. DR GeneTree; ENSGT00940000159884; -. DR HOGENOM; CLU_010747_0_0_1; -. DR InParanoid; O75362; -. DR OMA; IHKNCRS; -. DR OrthoDB; 3849084at2759; -. DR PhylomeDB; O75362; -. DR TreeFam; TF332241; -. DR PathwayCommons; O75362; -. DR Reactome; R-HSA-9018519; Estrogen-dependent gene expression. DR SignaLink; O75362; -. DR SIGNOR; O75362; -. DR BioGRID-ORCS; 7764; 279 hits in 1214 CRISPR screens. DR ChiTaRS; ZNF217; human. DR EvolutionaryTrace; O75362; -. DR GeneWiki; ZNF217; -. DR GenomeRNAi; 7764; -. DR Pharos; O75362; Tbio. DR PRO; PR:O75362; -. DR Proteomes; UP000005640; Chromosome 20. DR RNAct; O75362; Protein. DR Bgee; ENSG00000171940; Expressed in endometrium epithelium and 177 other cell types or tissues. DR ExpressionAtlas; O75362; baseline and differential. DR GO; GO:0000118; C:histone deacetylase complex; IDA:UniProtKB. DR GO; GO:0005739; C:mitochondrion; IDA:HPA. DR GO; GO:0016607; C:nuclear speck; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB. DR GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB. DR GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB. DR GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB. DR Gene3D; 3.30.160.60; Classic Zinc Finger; 5. DR IDEAL; IID00188; -. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR PANTHER; PTHR45925; ZINC FINGER PROTEIN; 1. DR PANTHER; PTHR45925:SF4; ZINC FINGER PROTEIN 217; 1. DR Pfam; PF00096; zf-C2H2; 4. DR SMART; SM00355; ZnF_C2H2; 8. DR SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7. DR Genevisible; O75362; HS. PE 1: Evidence at protein level; KW 3D-structure; DNA-binding; Isopeptide bond; Metal-binding; Nucleus; KW Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription; KW Transcription regulation; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..1048 FT /note="Zinc finger protein 217" FT /id="PRO_0000047460" FT ZN_FING 65..88 FT /note="C2H2-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 128..150 FT /note="C2H2-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 156..178 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 216..238 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 375..397 FT /note="C2H2-type 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 471..493 FT /note="C2H2-type 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 499..521 FT /note="C2H2-type 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 242..262 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 315..375 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 395..457 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 644..670 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 772..883 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 242..260 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 318..333 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 345..375 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 435..457 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 805..845 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 869..883 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 106 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 321 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 322 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 407 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692, FT ECO:0007744|PubMed:23186163" FT MOD_RES 593 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 648 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 662 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 795 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692" FT CROSSLNK 819 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT VARIANT 323 FT /note="D -> N (in a colorectal cancer sample; somatic FT mutation; dbSNP:rs767530299)" FT /evidence="ECO:0000269|PubMed:16959974" FT /id="VAR_035572" FT VARIANT 739 FT /note="V -> I (in dbSNP:rs6063966)" FT /id="VAR_052795" FT VARIANT 889 FT /note="D -> G (in dbSNP:rs34323943)" FT /id="VAR_061939" FT TURN 474..476 FT /evidence="ECO:0007829|PDB:3UK3" FT HELIX 483..494 FT /evidence="ECO:0007829|PDB:3UK3" FT STRAND 502..505 FT /evidence="ECO:0007829|PDB:3UK3" FT STRAND 507..510 FT /evidence="ECO:0007829|PDB:3UK3" FT HELIX 511..521 FT /evidence="ECO:0007829|PDB:3UK3" SQ SEQUENCE 1048 AA; 115272 MW; 797FC620817D1E1F CRC64; MQSKVTGNMP TQSLLMYMDG PEVIGSSLGS PMEMEDALSM KGTAVVPFRA TQEKNVIQIE GYMPLDCMFC SQTFTHSEDL NKHVLMQHRP TLCEPAVLRV EAEYLSPLDK SQVRTEPPKE KNCKENEFSC EVCGQTFRVA FDVEIHMRTH KDSFTYGCNM CGRRFKEPWF LKNHMRTHNG KSGARSKLQQ GLESSPATIN EVVQVHAAES ISSPYKICMV CGFLFPNKES LIEHRKVHTK KTAFGTSSAQ TDSPQGGMPS SREDFLQLFN LRPKSHPETG KKPVRCIPQL DPFTTFQAWQ LATKGKVAIC QEVKESGQEG STDNDDSSSE KELGETNKGS CAGLSQEKEK CKHSHGEAPS VDADPKLPSS KEKPTHCSEC GKAFRTYHQL VLHSRVHKKD RRAGAESPTM SVDGRQPGTC SPDLAAPLDE NGAVDRGEGG SEDGSEDGLP EGIHLDKNDD GGKIKHLTSS RECSYCGKFF RSNYYLNIHL RTHTGEKPYK CEFCEYAAAQ KTSLRYHLER HHKEKQTDVA AEVKNDGKNQ DTEDALLTAD SAQTKNLKRF FDGAKDVTGS PPAKQLKEMP SVFQNVLGSA VLSPAHKDTQ DFHKNAADDS ADKVNKNPTP AYLDLLKKRS AVETQANNLI CRTKADVTPP PDGSTTHNLE VSPKEKQTET AADCRYRPSV DCHEKPLNLS VGALHNCPAI SLSKSLIPSI TCPFCTFKTF YPEVLMMHQR LEHKYNPDVH KNCRNKSLLR SRRTGCPPAL LGKDVPPLSS FCKPKPKSAF PAQSKSLPSA KGKQSPPGPG KAPLTSGIDS STLAPSNLKS HRPQQNVGVQ GAATRQQQSE MFPKTSVSPA PDKTKRPETK LKPLPVAPSQ PTLGSSNING SIDYPAKNDS PWAPPGRDYF CNRSASNTAA EFGEPLPKRL KSSVVALDVD QPGANYRRGY DLPKYHMVRG ITSLLPQDCV YPSQALPPKP RFLSSSEVDS PNVLTVQKPY GGSGPLYTCV PAGSPASSST LEGKRPVSYQ HLSNSMAQKR NYENFIGNAH YRPNDKKT //